These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

601 related articles for article (PubMed ID: 18656828)

  • 21. Long-term outcomes of patients with Barrett's esophagus and high-grade dysplasia or early cancer treated with endoluminal therapies with intention to complete eradication.
    Guarner-Argente C; Buoncristiano T; Furth EE; Falk GW; Ginsberg GG
    Gastrointest Endosc; 2013 Feb; 77(2):190-9. PubMed ID: 23317687
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of Barrett's esophagus with dysplasia.
    Hagen JA
    Semin Thorac Cardiovasc Surg; 1997 Jul; 9(3):285-9. PubMed ID: 9263347
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of proton pump inhibitors on markers of risk for high-grade dysplasia and oesophageal cancer in Barrett's oesophagus.
    Hillman LC; Chiragakis L; Shadbolt B; Kaye GL; Clarke AC
    Aliment Pharmacol Ther; 2008 Feb; 27(4):321-6. PubMed ID: 18047565
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Esophageal squamous cell carcinoma arising after endoscopic ablation therapy of Barrett's esophagus with high-grade dysplasia. Report of a case.
    Allende D; Dumot J; Yerian L
    Dis Esophagus; 2013 Apr; 26(3):314-8. PubMed ID: 23009180
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Advanced pathology under squamous epithelium on initial EMR specimens in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: implications for surveillance and endotherapy management.
    Chennat J; Ross AS; Konda VJ; Lin S; Noffsinger A; Hart J; Waxman I
    Gastrointest Endosc; 2009 Sep; 70(3):417-21. PubMed ID: 19555948
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Barrett's oesophagus--a pathologist's view.
    Fléjou JF; Svrcek M
    Histopathology; 2007 Jan; 50(1):3-14. PubMed ID: 17204017
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Technology insight: ablative techniques for Barrett's esophagus--current and emerging trends.
    Johnston MH
    Nat Clin Pract Oncol; 2005 Aug; 2(8):323-30. PubMed ID: 16130939
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of high-grade dysplasia in patients with Barrett's esophagus.
    Montgomery E; Canto MI
    Clin Gastroenterol Hepatol; 2006 Dec; 4(12):1434-9. PubMed ID: 17162237
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endoscopic mucosal resection of Barrett's oesophagus containing dysplasia or intramucosal cancer.
    Seewald S; Ang TL; Soehendra N
    Postgrad Med J; 2007 Jun; 83(980):367-72. PubMed ID: 17551066
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endoscopic therapy for Barrett's esophagus: a review of its emerging role in optimal diagnosis and endoluminal therapy.
    Dunki-Jacobs EM; Martin RC
    Ann Surg Oncol; 2012 May; 19(5):1575-82. PubMed ID: 22160480
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dysplasia in Barrett's esophagus: limitations of current management strategies.
    Spechler SJ
    Am J Gastroenterol; 2005 Apr; 100(4):927-35. PubMed ID: 15784042
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ultrahigh resolution optical coherence tomography of Barrett's esophagus: preliminary descriptive clinical study correlating images with histology.
    Chen Y; Aguirre AD; Hsiung PL; Desai S; Herz PR; Pedrosa M; Huang Q; Figueiredo M; Huang SW; Koski A; Schmitt JM; Fujimoto JG; Mashimo H
    Endoscopy; 2007 Jul; 39(7):599-605. PubMed ID: 17611914
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Porfimer sodium photodynamic therapy for management of Barrett's esophagus with high-grade dysplasia.
    Panjehpour M; Overholt BF
    Lasers Surg Med; 2006 Jun; 38(5):390-5. PubMed ID: 16788927
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Getting it "just right": the continued dilemma of the ideal treatment of Barrett's esophagus with early neoplasia.
    Peters JH
    Gastrointest Endosc; 2008 Apr; 67(4):602-3. PubMed ID: 18374023
    [No Abstract]   [Full Text] [Related]  

  • 35. Endoscopic therapy for Barrett's esophagus.
    Yeh RW; Triadafilopoulos G
    Gastrointest Endosc Clin N Am; 2005 Jul; 15(3):377-97, vii. PubMed ID: 15990048
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment for Barrett's oesophagus.
    Rees JR; Lao-Sirieix P; Wong A; Fitzgerald RC
    Cochrane Database Syst Rev; 2010 Jan; 2010(1):CD004060. PubMed ID: 20091557
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Editorial: Resecting or burning: what should we do with the remaining barrett's epithelium after successful ER of neoplasia?
    Pech O; Ell C
    Am J Gastroenterol; 2009 Nov; 104(11):2693-4. PubMed ID: 19888235
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of cancer risk in Barrett's esophagus.
    Tan A; Macrae F
    J Gastroenterol Hepatol; 2011 Oct; 26(10):1485-92. PubMed ID: 21592226
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stepwise radical endoscopic resection for Barrett's esophagus with early neoplasia: report on a Brussels' cohort.
    Pouw RE; Peters FP; Sempoux C; Piessevaux H; Deprez PH
    Endoscopy; 2008 Nov; 40(11):892-8. PubMed ID: 19009481
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Histological assessment of oesophageal columnar mucosa.
    Flejou JF
    Best Pract Res Clin Gastroenterol; 2008; 22(4):671-86. PubMed ID: 18656824
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.